20086 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
DRIED FORMULATIONS
#902Preparation of pharmaceutical compositions
#903Methods of processing compositions containing microparticles
#904Hot-melt extrusion of modified release multi-particulates
#905Methods of processing compositions containing microparticles
#906HYDROBROMIDE SALT OF AN ANTI-HIV COMPOUND
#907METHOD OF MAKING SOLID DISPERSIONS OF HIGHLY CRYSTALLINE THERAPEUTIC COMPOUNDS
#908Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#909Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#910PHARMACEUTICAL COMPOSITIONS CONTAINING HEPARIN DERIVATIVES
#911Formulations with Improved Bioavailability
#912METHOD OF TREATMENT FOR OSTEOARTHRITIS BY LOCAL INTRA-ARTICULAR INJECTION OF MICROPARTICLES
#913anti-parasitic compositions
#914Pharmaceutical compositions
#915SOLID DISPERSION OF A NEUROKININ ANTAGONIST
#916TRIGGERED RELEASE OF DRUGS FROM POLYMER PARTICLES
#917Rapid-Melt Compositions and Methods of Making Same
#918Processes for preparing pharmaceutical compositions
#919Solid dispersions comprising tacrolimus
#920Biocompatible and biodegradable elastomeric polymers
#921Preparation of pharmaceutical formulations
#922BIOCOMPATIBLE POLYMER CERAMIC COMPOSITE MATRICES
#923Methods and kits for treating joints and soft tissues
#924Pellet Formulation Comprising Colloidal Silicon Dioxide
#925POLYMER MATRIX, METHOD FOR ITS PRODUCTION, AND ITS USE
#926Pharmaceutical compositions
#927Drug delivery system and method of making the same
#928Device coated with glycogen particles comprising nucleic acid complexes
#929Process for manufacturing chewable dosage forms for drug delivery and products thereof
#930Rehydratable pharmaceutical product
#931PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL
#932TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
#933Apparatus and methods for implanting particulate ocular implants
#934Methods and compositions for treating pain comprising a statin
#935Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
#936Taste-masking oral dosage form and method of preparing the same
#937METHODS OF TREATMENT WITH DRUG LOADED POLYMERIC MATERIALS
#938Biocidal compositions
#939Cell Transport Compositions and Uses Thereof
#940Main chain acid-degradable polymers for the delivery of bioactive materials
#941ORALLY DISINTEGRATING TABLET COMPOSITIONS OF RANITIDINE AND METHODS OF MANUFACTURE
#942Bupivacaine formulation in a polyorthoester carrier
#943PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)
#944Residual solvent extraction method and microparticles produced thereby
#945Nanodispersions
#946Process for preparing microparticles having a low residual solvent volume
#947Chewable formulations
#948PHARMACEUTICAL COMPOSITIONS
#949Swellable hydrogel matrix and methods
#950Controlled release tramadol formulations
#951CHARGED BIODEGRADABLE POLYMERS FOR MEDICAL APPLICATIONS
#952Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
#953Compositions comprising lipophilic active compounds and method for their preparation
#954Multi-component particles for injection and processes for forming the same
#955CROSS-LINKED POLYMER PARTICLES
#956NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
#957Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same
#958Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus
#959Tamper resistant dosage forms
#960Pharmaceutical composition containing gelling agent
#961Sustained-release formulation
#962ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#963Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
#964Drug delivery vehicle that mimics viral properties
#965Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
#966ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#967METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE
#968ENHANCED FORMULATIONS OF LAMOTRIGINE
#969Pharmaceutical excipient complex
#970Compositions controlling pH range of release and/or release rate
#971Ginger Extract For Inhibiting Human Drug Transporters
#972Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof
#973Drug-delivery systems
#974Self-precipitating pharmaceutical formulations for the modified release of an active principle
#975Pharmaceutical compositions for gastrointestinal drug delivery
#976Dosage form with impeded abuse
#977Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
#978Vesicles for active macromolecule delivery
#979ENTERIC COATED, SOLUBLE CREATINE AND POLYETHYLENE GLYCOL COMPOSITION FOR ENHANCED SKELETAL UPTAKE OF ORAL CREATINE
#980Amorphous aripiprazole and process for the preparation thereof
#981Stabilized HME composition with small drug particles
#982GLUCAGON-LIKE PEPTIDE 1 (GLP-1) PHARMACEUTICAL FORMULATIONS
#983VITAMIN D3 ANALOG LOADED POLYMER FORMULATIONS FOR CANCER AND NEURODEGENERATIVE DISORDERS
#984STABLE SOLID DISPERSION OF A DERIVATIVE OF VINCA ALKALOID AND PROCESS FOR MANUFACTURING IT
#985Pharmaceutical composition and process
#986Sustained release composition of protein drug
#987High pressure spray-dry of bioactive materials
#988Particles for inhalation having sustained release properties
#989Preparation of polyphosphazene microspheres
#990Dispersion for pulmonary delivery of a bioactive agent
#991Respiratory dispersion for metered dose inhalers
#992Particles comprising a releasable dopant therein
#993Pharmaceutical Preparation Containing Gabapentin
#994Effect of LMP-1 overexpression on large and small proteoglycans of the disc
#995PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED INDOLE ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
#996Oral Dosage Form
#997Treatment of Pain
#998ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#999Compositions and methods for treating or preventing imflammatory diseases
#1000Amorphous Taclolimus Solid Dispersion Having an Enhanced Solubility and Pharmaceutical Composition Comprising Same
#1001PHARMACEUTICAL DOSAGE FORMS OF OXCARBAZEPINE
#1002Polyarylates for drug delivery and tissue engineering
#1003Novel modified release formulation
#1004Compositions and methods for treating or preventing inflammatory diseases
#1005Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#1006COMPOSITIONS COMPRISING NANOPARTICULATE MELOXICAM AND CONTROLLED RELEASE HYDROCODONE
#1007Nanoparticles Of Chitosan And Polyethyleneglycol As A System For The Administration Of Biologically-Active Molecules
#1008Amorphous ezetimibe and the production thereof
#1009ENHANCEMENT OF LENS REGENERATION USING MATERIALS COMPRISING POLYMERS
#1010METHOD FOR TREATING NEOVASCULARIZATION AND INTRAVITREAL IMPLANTS
#1011Prolonged-release multimicroparticulate oral pharmaceutical form
#1012MINIMIZATION OF DRUG OXIDATION IN DRUG IRRADIATED EXCIPIENTS FORMULATIONS
#1013Pharmaceutical Compositions
#1014Residual solvent extraction method and microparticles produced thereby
#1015Residual solvent extraction method and microparticles produced thereby
#1016METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA
#1017Methods for reducing edema
#1018Preparation of injectable suspensions having improved injectability
#1019Preparation of injectable suspensions having improved injectability
#1020Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#1021Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
#1022Swellable particles for drug delivery
#1023ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1024Amorphous aripiprazole and process for the preparation thereof
#1025AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS
#1026Methods of treatment with drug loaded polymeric materials
#1027Responsive microgel and methods related thereto
#1028ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1029Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
#1030Steroid-containing sustained release intraocular implants and related methods
#1031Apparatus and methods for implanting particulate ocular implants
#1032Controlled agglomeration
#1033Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
#1034TRIGGERED RELEASE FROM PROTEINOID MICROSPHERES
#1035Nanoparticles for delivery of active agents
#1036Solid dosage form of wetted heparin
#1037Dispersion for pulmonary delivery of a bioactive agent
#1038Pharmaceutical composition and process
#1039Residual solvent extraction method and microparticles produced thereby
#1040Method for the production of emulsion-based microparticles
#1041Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
#1042Pharmaceutical composition and process
#1043Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers
#1044METHODS AND GEL COMPOSITIONS FOR ENCAPSULATING LIVING CELLS AND ORGANIC MOLECULES
#1045Method of treatment for osteoarthritis by local intra-articular injection of microparticles
#1046Solid compositions of low-solubility drugs and poloxamers
#1047Process for manufacturing chewable dosage forms for drug delivery and products thereof
#1048Method for preparing modified release pharmaceutical compositions
#1049Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
#1050Pharmaceutical compositions comprising lercanidipine
#1051Medicament sustained-release particles and method for preparing the same
#1052Therapeutic compositions
#1053Pharmaceutical formulation
#1054Capsules comprising topiramate
#1055Novel dosage formulation
#1056Macromer-melt formulations
#1057Pharmaceutical composition containing levodopa and carbidopa
#1058Treatment of allergic conditions
#1059Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
#1060Formulations of fenofibrate containing PEG/Poloxamer
#1061Formulations of fenofibrate containing menthol
#1062PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN
#1063Particles for inhalation having sustained release properties
#1064IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM
#1065Method for preparing powder exhibiting low susceptibility to electrification
#1066Anti-angiogenic compositions and methods of use
#1067Anti-angiogenic compositions and methods of use
#1068Biodegradable phase separated segmented multi block co-polymers
#1069Modified release compositions comprising tacrolimus
#1070Taste-masked pharmaceutical particle, the preparation and use thereof
#1071Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
#1072Controlled release tramadol formulations
#1073Pharmaceutical compositions comprising clavulanic acid
#1074Compositions containing micronized tanaproget prepared by wet granulation
#1075Anti-angiogenic compositions and methods of use
#1076Methods for treating neovascularization and intravitreal implants
#1077Composite materials and particles
#1078Polymer compositions for administration to animals
#1079Pulmonary delivery particles comprising water insoluble or crystalline active agents
#1080Pulmonary delivery particles with phospholipid structural matrix
#1081Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
#1082Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
#1083Beads for capturing target cells from bodily fluid
#1084Sustained-release nanoparticle compositions and methods for using the same
#1085Oral drug delivery compositions and methods
#1086Anti-angiogenic compositions and methods of use
#1087Devices and compositions containing boron and silicon for use in neutron capture therapy
#1088Sustained release ionic conjugate
#1089Anti-angiogenic compositions and methods of use
#1090Formulations of substituted benzoxazoles
#1091Micropellets method for the production thereof, and use thereof
#1092Method for preparation of an agglomerate using melt agglomeration
#1093Residual solvent extraction method and microparticles produced thereby
#1094Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#1095Microparticles and nanoparticles containing a lipopolymer
#1096Method for the preparatin of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby
#1097Injectable hydrogel microspheres from aqueous two-phase system
#1098Simultaneous encapsulation technique for use in pharmaceutical compositions
#1099Solid dispersion compositions
#1100Method of microencapsulation
#1101Controlled regional oral delivery
#1102Azithromycin dosage forms with reduced side effects
#1103Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
#1104Azithromycin dosage forms with reduced side effects
#1105Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
#1106Therapeutic polyanhydride compounds for drug delivery
#1107Slow release protein polymers
#1108Pharmaceutical compositions with synchronized solubilizer release
#1109Methods of treatment with drug loaded polymeric materials
#1110Targeted and high density drug loaded polymeric materials
#1111Method of forming microparticles that include a bisphosphonate and a polymer
#1112Active agent transport systems
#1113Pharmaceutical compositions of lipase-containing products, in particular of pancreation
#1114Polymeric drug delivery system for hydrophobic drugs
#1115Compositions and methods for treating or preventing inflammatory diseases
#1116Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
#1117Naltrexone long acting formulations and methods of use
#1118Bazedoxifene acetate formulations
#1119Pharmaceutical composition
#1120Anti-angiogenic compositions and methods of use
#1121Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
#1122Multiparticulate crystalline drug compositions having controlled release profiles
#1123Extrusion process for forming chemically stable drug multiparticulates
#1124Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
#1125Sustained-release formulation
#1126Polyarylates for drug delivery and tissue engineering
#1127Rosiglitazone formulations
#1128Azithromycin multiparticulate dosage forms by melt-congeal processes
#1129Minimization of drug oxidation in drug irradiated excipients formulations
#1130Release sustaining composition and sustained release preparation
#1131Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
#1132Enhanced absorption of modified release dosage forms
#1133Crosslinkable macromers
#1134Non-donating nsaids adsorbed into carrier particles
#1135Azithromycin dosage forms with reduced side effects
#1136Controlled release dosage forms of azithromycin
#1137Anti-angiogenic compositions and methods of use
#1138Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens
#1139Multi component controlled release system for oral care, food products, nutraceutical, and beverages
#1140Method of encapsulating an active substance
#1141Medicinal composition
#1142Medicinal composition
#1143Drug delivery system for the subconjunctival administration of fine grains
#1144Residual solvent extraction method and microparticles produced thereby
#1145Model for testing immunogenicity of peptides
#1146Engineered particles and methods of use
#1147Compositions of polyacids and methods for their use in reducing adhesions
#1148Sustained release ionic conjugate
#1149Antibiotic product, use and formulation thereof
#1150Immediate release pharmaceutical granule compositions and a continuous process for making them
#1151GLP-1 formulations with protracted time action
#1152Poly-4-hydroxybutyrate matrices for sustained drug delivery
#1153Functional powders for oral delivery
#1154Solid dispersions comprising a hygroscopic and/or deliquescent drug
#1155Controlled agglomeration
#1156Duloxetine sprinkles
#1157Bendamustine pharmaceutical compositions
#1158Abuse resistant pharmaceutical compositions
#1159Therapeutic composition with enhanced vessel targeting
#1160Solid telmisartan pharmaceutical formulations
#1161Microspheres of pancreatic enzymes with high stability and production method thereof